NCT00630474

Nasal Decongestion and Obstructive Sleep Apnea

Does Nasal Decongestion Improve Obstructive Sleep Apnea ?

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 12 (actual)
• Sponsor: University of Zurich · Academic / Other
• Sex: All
• Age: 20 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

Whether impaired nasal breathing contributes to sleep related breathing disturbances has not been known. Therefore, the purpose of the study is to compare the effect of xylometazoline, a drug that decongests the nasal mucosa when applied locally, with placebo in terms of sleep and nocturnal breathing and daytime performance.

Conditions

• Obstructive Sleep Apnea Syndrome
• Rhinitis

Interventions

Type	Name	Description
DRUG	xylometazoline	xylometazoline (0.1 % solution, 3 drops, 0.15 mg) in each nostril

Timeline

• Start date: 2004-01-01
• Primary completion: 2005-04-01
• Completion: 2005-04-01
• First posted: 2008-03-07
• Last updated: 2009-12-23

Locations

2 sites across 1 country: Switzerland